MHRA launches project to involve patients in drug approval process News item 03 April 2021 Pages: 1 - 1
Chemotherapy-free SC mobilisation cost effective in multiple myeloma Clinical study 03 April 2021 Pages: 2 - 2
COBRA-BPS programme cost effective for hypertension in Asia Clinical study 03 April 2021 Pages: 3 - 3
Combination therapy in systemic sclerosis-related pulmonary arterial hypertension: survival benefits at high cost Clinical study 03 April 2021 Pages: 4 - 4
Costs for late-stage Parkinson's disease in Germany determined Clinical study 03 April 2021 Pages: 5 - 5
Discontinuing chemotherapy for oesophageal cancer cost effective? Clinical study 03 April 2021 Pages: 6 - 6
Empirical bismuth-based quadruple therapy for H. pylori eradication: effective, less costly Clinical study 03 April 2021 Pages: 9 - 9
Gene therapy for sickle cell disease: high Medicaid budget impact Clinical study 03 April 2021 Pages: 10 - 10
Global estimates for lifetime cost of managing HIV: significant variations in the literature Review 03 April 2021 Pages: 11 - 11
Heart failure-related resource use and costs are substantial in USA Clinical study 03 April 2021 Pages: 12 - 12
Hydroxychloroquine valid option in autoantibody-negative rheumatoid arthritis Clinical study 03 April 2021 Pages: 13 - 13
Increase in payments for neurologist-prescribed brand name drugs Clinical study 03 April 2021 Pages: 14 - 14
Increased global interest in evidence-based approach by decision-makers for introduction of new vaccines Review 03 April 2021 Pages: 15 - 15
Intensive antihypertensive treatment saves lives at acceptable cost in China Clinical study 03 April 2021 Pages: 16 - 16
Meningococcal serogroup B vaccination: substantial benefits but not cost effective Review 03 April 2021 Pages: 17 - 17
Non-alcoholic steatohepatitis substantial burden in the UK Clinical study 03 April 2021 Pages: 18 - 18
Nonavalent vaccine for school-based HPV vaccination programme in Singapore: benefits at high cost Clinical study 03 April 2021 Pages: 19 - 19
Norovirus vaccination cost effective in children in daycare Clinical study 03 April 2021 Pages: 20 - 20
Novel therapies not cost effective for MM in the Netherlands Clinical study 03 April 2021 Pages: 21 - 21
Pembrolizumab monotherapy cost effective in metastatic non-squamous NSCLC with high PD-L1 expression in Switzerland Clinical study 03 April 2021 Pages: 23 - 23
Pravastatin cost effective for preventing atherosclerotic CVD in people with HIV Clinical study 03 April 2021 Pages: 24 - 24
Preschool peanut immunotherapy cost effective in US and Canada Clinical study 03 April 2021 Pages: 26 - 26
Psychiatric comorbidities increase costs in patients with MDD Clinical study 03 April 2021 Pages: 27 - 27
Rivaroxaban + aspirin cost effective in CAD and/or PAD in Italy Clinical study 03 April 2021 Pages: 28 - 28
Short-duration bendamustine ready-to-dilute product in CLL/NHL: clinical and economic advantages Clinical study 03 April 2021 Pages: 29 - 29
Strong support for universal access to assistive reproductive therapies and WTP in a multi-country survey Non-clinical study 03 April 2021 Pages: 30 - 30
Total knee replacement good value in patients with high BMI Clinical study 03 April 2021 Pages: 31 - 31
Understanding WTP for childhood malaria vaccine in Northwest Ethiopia Non-clinical study 03 April 2021 Pages: 32 - 32
Universal HIV testing and treatment cost effective in Zambia and SA Clinical study 03 April 2021 Pages: 33 - 33